How Will New Products & Therapeutic Innovations Impact Pharma
Robert E. Perks, MSc, CEng
Lisa J. Graham, PhD, PE
Sarah Mancini, PhD
The Product Development & Product Systems Track at the 2018 ISPE Annual Meeting & Expo
The pharmaceutical industry is coming out with new product and therapeutic innovations at a rapid pace. For example, cell and gene therapy is one of the many areas exploding with possibilities for novel treatments of formerly life-threatening conditions. The pressure to bring these new treatments to market quickly, efficiently, and with dependable quality has increased accordingly. Alongside this explosion of innovative solutions is an expectation to continuously improve your products and processes.
The Product Development and Product Systems track at the 2018 ISPE Annual Meeting & Expo in Philadelphia, PA, USA will address this paradigm shift with sessions and workshops presented by experienced practitioners who will share their experiences and solutions to today’s challenges.
The Product Development and Product Systems track will explore how new technologies and thinking will change the product development and manufacturing processes, and their impact on the future state of the industry, through the integration of:
Data analysis and other technologies and methodologies
The following topics will be covered:
Pharma 4.0™ and the Production Control Strategy
Knowledge Management and Data Analysis
The Product Development and Product Systems track team looks forward to meeting with you in Philadelphia this November to discuss challenges and share knowledge and solutions.
Growth-oriented, technology CEO with more than 20 years of experience across process industries and software organizations. Expertise in effectively managing global organization, operations, mergers and...
Are you considering joining ISPE? Or maybe you’ve recently joined the society or are a longtime member looking to better understand all the benefits available to you. If so, you’ve come to the right place!
ATMPs are based on genes, cells or tissues delivered to patients to provide a therapeutic benefit based on a specific target of interest. Often referred to as ‘Personalised Medicine’. A sector of healthcare that is rapidly evolving and expanding with some unique challenges such as microbial contamination and product variability. Traditional manufacturing processes are for synthetically derived...
GAMP® 5 Second Edition is here! Since its publication, GAMP® 5 has been far and away the leading international guidance on GxP computerized systems validation and compliance, and it was time to update our guidance to...